Clinical Trial Update: Triple vs. Dual Adjuvant Therapy Following Liver Resection for HCC. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing triple versus dual adjuvant therapy after liver resection in hepatocellular carcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Chen Xiaoping | Conditions: HCC | Phase 4 | Status: RECRUITING